Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index; 23 of the 29 sources its claims cite were checked for support.

A post-implementation evaluation of BioFire FilmArray Meningitis/Encephalitis panel for pathogen detection in cerebrospinal fluid with a special focus on clinical significance of HHV-6

Open access
Perera, Manoshi, Varadhan, Hemalatha, Oon, Aileen · 2026 · Microbiology spectrum

Abstract

Syndromic molecular testing for the diagnosis of infections has been advantageous given high sensitivity and rapid diagnostics; however, challenges remain with appropriate interpretation. A post-implementation evaluation of the cerebrospinal fluid (CSF) BioMerieux BioFire FilmArray Meningitis/Encephalitis panel in an adult and pediatric population was performed. The aims were to assess the prevalence and epidemiology of all targets and to correlate laboratory parameters with results from human herpesvirus 6 (HHV-6) detection in CSF to identify opportunities to apply diagnostic stewardship. A retrospective observational study was conducted on CSF Nucleic Acid Amplification Test (NAAT) results performed at a referral laboratory in Australia between 19 March 2022 and 31 July 2023. Laboratory data were extracted, with additional clinical data obtained for the HHV-6 positive subcohort. Of 1,490 CSF specimens identified, 287 (19.3%) had a positive NAAT. Non-neonate CSF specimens with white cell count (WCC) above the normal range had a higher proportion of NAAT-positive rates (35.3%) compared to those with WCC < 5 × 10 6 cells/L (6.5%) ( P < 0.001). A positive NAAT result was detected in 90 (39.1%) specimens in neonates, with enterovirus and parechovirus detected most frequently. Concordance of bacterial and fungal targets and culture results was seen in 16 (33.3%) specimens. Forty-eight CSF specimens had HHV-6 detected, with a median age of 24.3 years (interquartile range: 0.5–58.7) at collection and 10 specimens with a documented immunocompromised status. This study highlights the caution required when utilizing syndromic diagnostic assays for the detection of CSF pathogens without associated diagnostic stewardship strategies and the potential utility of CSF WCC as a criterion for further review. IMPORTANCE Utilization of molecular testing methods enables rapid and high-sensitivity diagnostics, which can have significant impacts upon clinical outcomes in meningitis and encephalitis. However, challenges remain with the interpretation of results when syndromic panels are used, such as with the detection of human herpesvirus 6 (HHV-6) in cerebrospinal fluid (CSF). This study aimed to evaluate the BioMerieux BioFire FilmArray Meningitis/Encephalitis panel for the detection of pathogens in CSF in an adult and pediatric population. Data demonstrated that performing CSF nucleic acid amplification testing without diagnostic stewardship strategies in place can be associated with increased detection of potential bystander pathogens, including HHV-6.

Overview

CoChat Summary

## TL;DR

This retrospective post-implementation study of 1,490 CSF specimens found that BioFire FilmArray Meningitis/Encephalitis testing was positive in 19.3% overall, with HHV-6 detected in 48 specimens (3.2%). The authors conclude that HHV-6 in CSF is often hard to interpret and that using CSF white cell count as a stewardship trigger for non-neonate samples may reduce low-value testing.

## Key findings

  • Among 1,490 CSF specimens from 1,457 patients, 287 specimens (19.3%) were NAAT-positive; 5 specimens (0.3%) had more than one organism detected.
  • Enterovirus was the most common target overall, detected in 130 specimens (8.7%); HHV-6 was detected in 48 specimens (3.2%).
  • For non-neonate specimens, NAAT positivity was 35.3% when CSF WCC was above the normal range versus 6.5% when WCC was within normal range (P < 0.001).
  • In the HHV-6-positive subcohort, 41.7% of specimens had CSF RBC above the normal range, 25% (12/48) had elevated protein, and 14.6% (7/48) received antiviral therapy; 10 specimens had documented immunocompromised status.

## Methods

  • Retrospective observational study at a single referral laboratory in Newcastle, Australia, covering 19 March 2022 to 31 July 2023.
  • Included pediatric and adult CSF specimens obtained by lumbar puncture with at least 200 µL collected; excluded forensic, repeat same-admission, and out-of-region specimens.
  • Extracted laboratory and clinical data from the LIS and used descriptive statistics plus chi-square tests to compare categorical variables.

## Limitations

  • The paper explicitly states it was retrospective and had reduced sample size in some subcohorts; no power calculations were performed.
  • Full clinical and laboratory data were not available on all patients, and there was no data on the prevalence of ciHHV-6 or radiological imaging to support HHV-6 encephalitis diagnoses.
  • Evident from the text: HHV-6 serology and quantitative testing were only done in a minority of HHV-6-positive cases, which limits interpretation of whether detections represented infection, reactivation, or chromosomal integration.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1128/spectrum.00620-25

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig 1 (A) Proportion of positive CSF NAAT panel targets for the subcohort of neonates (≤1 month). (B) Proportion of positive CSF NAAT panel targets for the subcohort of children (between 1 month and 18 years). (C) Proportion of positive CSF NAAT panel targets for the subcohort of adults (≥18 years).
Fig 1 (A) Proportion of positive CSF NAAT panel targets for the subcohort of neonates (≤1 month). (B) Proportion of positive CSF NAAT panel targets for the subcohort of children (between 1 month and 18 years). (C) Proportion of positive CSF NAAT panel targets for the subcohort of adults (≥18 years).CC BY · PubMed Central
Fig 2 Comparison of positive NAAT targets in patients with elevated CSF WCC (non-neonates ≥ 5 × 106 cells/L, neonates ≥ 20 × 106 cells/L) to patients with a WCC within normal range (non-neonates < 5 × 106 cells/L, neonates < 20 × 106 cells/L). WCC was not recorded for 13 specimens.
Fig 2 Comparison of positive NAAT targets in patients with elevated CSF WCC (non-neonates ≥ 5 × 106 cells/L, neonates ≥ 20 × 106 cells/L) to patients with a WCC within normal range (non-neonates < 5 × 106 cells/L, neonates < 20 × 106 cells/L). WCC was not recorded for 13 specimens.CC BY · PubMed Central

Verification

Claims the paper makes

17 Valid · 3 Not valid · 4 Not checked · 44 Own results and interpretations

28 more claims · 2 with their cited sources checked

Create a free account to see all 68 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 21
  • Probably not a substantial claim. 23
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Show all 29 references

Cited by

See all 4

Metadata

Authors
Perera, M., Varadhan, H., & Oon, A.
Affiliations
John Hunter Hospital (AU)
Corresponding author
Perera, Manoshi
Venue
Microbiology spectrum
Published
2026-01-06
Volume
14
Issue
1
Pages
e0062025-e0062025
ISSN
2165-0497 (ISSN-L)
OpenAlex
W4416790464
Cited by
4
References
29
Citations by year
2026: 4
FWCI
3.05
Type
journal article
Language
en
Open access
Licence
Locations
  • Microbiology Spectrum (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
  • Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
Keywords
cerebrospinal fluid, meningitis, encephalitis, human herpesvirus 6, nucleic acid amplification tests, diagnostic stewardship, enterovirus, parechovirus, immunocompromised patients
MeSH terms
Clinical Relevance, Adolescent, Adult, Australia, Cerebrospinal Fluid, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Male, Meningitis, Middle Aged, Retrospective Studies, Sensitivity and Specificity, Herpesvirus 6, Human, Encephalitis, Viral, Roseolovirus Infections, Nucleic Acid Amplification Techniques, Molecular Diagnostic Techniques, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A post-implementation evaluation of BioFire FilmArray Meningitis/Encephalitis panel for pathogen detection in cerebrospinal fluid with a special focus on clinical significance of HHV-6. https://app.cochat.ai/papers/10.1128/spectrum.00620-25
The paper
Perera, M., Varadhan, H., & Oon, A. (2026). A post-implementation evaluation of BioFire FilmArray Meningitis/Encephalitis panel for pathogen detection in cerebrospinal fluid with a special focus on clinical significance of HHV-6. Microbiology spectrum. https://doi.org/10.1128/spectrum.00620-25

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.